Almost 800 terminally ill cancer patients already participate in clinical trials being run by the 19 experimental cancer medicine centres.
They are people whose NHS treatment has either not worked or stopped working. Each trial involves patients taking either an experimental drug, or an existing treatment usually used in other cancers, or a standard chemotherapy drug taken with either an unlicensed or established drug.
Unlike some other clinical trials, these patients are not paid. They take part to give themselves a chance of extra life, to help future generations of cancer sufferers and also to involve them in something positive at an otherwise depressing time.
Read Further
Comments